These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 16172569

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [99mTc-OCTREOTIDE in patients with neuroendocrine tumors from the GI tract].
    Gómez M, Ferrando R, Vilar J, Hitateguy R, López B, Moreira E, Kapitán M, De Lima F, Agüero B, Gabriela Villegas M, Urdaneta N, Gutiérrez E, Battegazzore A, Bayardo K, Silveira A, Lago G, Páez A.
    Acta Gastroenterol Latinoam; 2010 Dec; 40(4):332-8. PubMed ID: 21381408
    [Abstract] [Full Text] [Related]

  • 3. Specificity and sensitivity of ⁹⁹mTc-EDDA/HYNIC-Tyr³-octreotide (⁹⁹mTc-TOC) for imaging neuroendocrine tumors.
    Sepúlveda-Méndez J, de Murphy CA, Pedraza-López M, Murphy-Stack E, Rojas-Bautista JC, González-Treviño O.
    Nucl Med Commun; 2012 Jan; 33(1):69-79. PubMed ID: 21970835
    [Abstract] [Full Text] [Related]

  • 4. 99mTc-HYNIC-TOC imaging in the evaluation of pancreatic masses which are potential neuroendocrine tumors.
    Qiao Z, Zhang J, Jin X, Huo L, Zhu Z, Xing H, Li F.
    Clin Nucl Med; 2015 May; 40(5):397-400. PubMed ID: 25706799
    [Abstract] [Full Text] [Related]

  • 5. Clinical indications to the use of (99m)Tc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors.
    Parisella MG, Chianelli M, D'Alessandria C, Todino V, Mikolajczak R, Papini E, Dierckx RA, Scopinaro F, Signore A.
    Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):90-8. PubMed ID: 21068709
    [Abstract] [Full Text] [Related]

  • 6. Incremental value of 99mTc-HYNIC-TOC SPECT/CT over whole-body planar scintigraphy and SPECT in patients with neuroendocrine tumours.
    Trogrlic M, Težak S.
    Nuklearmedizin; 2017 Jun 12; 56(3):97-107. PubMed ID: 28164207
    [Abstract] [Full Text] [Related]

  • 7. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
    Gabriel M, Decristoforo C, Donnemiller E, Ulmer H, Watfah Rychlinski C, Mather SJ, Moncayo R.
    J Nucl Med; 2003 May 12; 44(5):708-16. PubMed ID: 12732671
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
    Madrzak D, Mikołajczak R, Kamiński G.
    Nucl Med Rev Cent East Eur; 2016 May 12; 19(2):88-92. PubMed ID: 27479886
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
    Schillaci O, Spanu A, Scopinaro F, Falchi A, Danieli R, Marongiu P, Pisu N, Madeddu G, Delle Fave G, Madeddu G.
    J Nucl Med; 2003 Mar 12; 44(3):359-68. PubMed ID: 12621001
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of neuroendocrine tumors with 99mTc-EDDA/HYNIC TOC.
    Artiko V, Afgan A, Petrović J, Radović B, Petrović N, Vlajković M, Šobić-Šaranović D, Obradović V.
    Nucl Med Rev Cent East Eur; 2016 Mar 12; 19(2):99-103. PubMed ID: 27479786
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours.
    Gabriel M, Hausler F, Bale R, Moncayo R, Decristoforo C, Kovacs P, Virgolini I.
    Eur J Nucl Med Mol Imaging; 2005 Dec 12; 32(12):1440-51. PubMed ID: 16133384
    [Abstract] [Full Text] [Related]

  • 18. Clinical application of 99mTc-HYNIC-TOC SPECT/CT in diagnosing and monitoring of pancreatic neuroendocrine neoplasms.
    Xu J, Li Y, Xu X, Zhang J, Zhang Y, Yu X, Huang D.
    Ann Nucl Med; 2018 Aug 12; 32(7):446-452. PubMed ID: 29926342
    [Abstract] [Full Text] [Related]

  • 19. Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.
    Schillaci O, Corleto VD, Annibale B, Scopinaro F, Delle Fave G.
    Ital J Gastroenterol Hepatol; 1999 Oct 12; 31 Suppl 2():S186-9. PubMed ID: 10604127
    [Abstract] [Full Text] [Related]

  • 20. Clinical application of SPECT-CT with 99mTc-Tektrotyd in bronchial and thymic neuroendocrine tumors (NETs).
    Sergieva S, Robev B, Dimcheva M, Fakirova A, Hristoskova R.
    Nucl Med Rev Cent East Eur; 2016 Oct 12; 19(2):81-7. PubMed ID: 27479885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.